White & Case Guides $825M Takeda Drug Divestment
Guided by White & Case, Takeda said Monday it is selling an $825 million portfolio of pharmaceuticals to Brazil's Hypera Pharma, continuing the Japanese company's strategy to shed $10 billion in...To view the full article, register now.
Already a subscriber? Click here to view full article